Mar 15, 2023 / 02:40PM GMT
Justin Alexander Kim - Oppenheimer & Co. Inc., Research Division - Associate
Great. So good morning, everyone, and thanks for joining us for day 3 of Oppenheimer's Annual Healthcare Conference. I'm Justin Kim, one of the research analysts at OpCo and it's my pleasure to host this fireside chat session with Ionis Pharmaceuticals and CEO, Dr. Brett Monia. So thanks for joining us, Brett. It's great to have you here.
Brett P. Monia - Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Thank you, Justin. Good morning. Good morning, everybody. Thanks for joining.
Justin Alexander Kim - Oppenheimer & Co. Inc., Research Division - Associate
Maybe just to start off, could you just give us an update on where the company stands today and sort of what lays ahead in 2023 and 2024?
Brett P. Monia - Ionis Pharmaceuticals, Inc. - Founder, CEO & Director
Yes, sure. Happy to, Justin. We, at Ionis, I am very pleased with the progress we're making across all aspects of the
Ionis Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot